CN1572293A - 一种水飞蓟素软胶囊及其制备方法 - Google Patents
一种水飞蓟素软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN1572293A CN1572293A CN 200410049484 CN200410049484A CN1572293A CN 1572293 A CN1572293 A CN 1572293A CN 200410049484 CN200410049484 CN 200410049484 CN 200410049484 A CN200410049484 A CN 200410049484A CN 1572293 A CN1572293 A CN 1572293A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- silymarin
- capsule according
- cosolvent
- stabilizing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 title claims abstract description 65
- 239000007901 soft capsule Substances 0.000 title claims abstract description 46
- SEBFKMXJBCUCAI-WAABAYLZSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2s,3s)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-WAABAYLZSA-N 0.000 title abstract description 8
- 238000000034 method Methods 0.000 title abstract description 7
- 239000003381 stabilizer Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000945 filler Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 9
- 239000002775 capsule Substances 0.000 claims abstract description 7
- 239000004014 plasticizer Substances 0.000 claims abstract description 5
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims description 57
- 235000017700 silymarin Nutrition 0.000 claims description 47
- 229960004245 silymarin Drugs 0.000 claims description 47
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- 238000002360 preparation method Methods 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 16
- 208000006454 hepatitis Diseases 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 239000006184 cosolvent Substances 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- 235000014899 silybin Nutrition 0.000 claims description 10
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 9
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 9
- 229950000628 silibinin Drugs 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 7
- 206010008909 Chronic Hepatitis Diseases 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 238000004513 sizing Methods 0.000 claims description 4
- 208000004930 Fatty Liver Diseases 0.000 claims description 3
- 206010019708 Hepatic steatosis Diseases 0.000 claims description 3
- 206010019759 Hepatitis chronic persistent Diseases 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 3
- 201000001352 cholecystitis Diseases 0.000 claims description 3
- 208000010706 fatty liver disease Diseases 0.000 claims description 3
- 231100000283 hepatitis Toxicity 0.000 claims description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims 2
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims 1
- 239000003292 glue Substances 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 description 13
- 230000008676 import Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 2
- CYGIJEJDYJOUAN-UHFFFAOYSA-N Isosilychristin Natural products C1=C(O)C(OC)=CC(C2C3C=C(C4C(C3=O)(O)OCC42)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 150000002333 glycines Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- FDQAOULAVFHKBX-KMRPREKFSA-N (+)-Isosilybin A Natural products C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC(=CC=C3O2)[C@@H]2[C@@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-KMRPREKFSA-N 0.000 description 1
- FDQAOULAVFHKBX-HKTJVKLFSA-N (2r,3r)-3,5,7-trihydroxy-2-[(2r,3r)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC(=CC=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-HKTJVKLFSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- KDMGQPNVTKUNHV-UHFFFAOYSA-N Isosilybin Natural products C1=C(O)C(OC)=CC=C1C1C(CO)OC2=CC=C(C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)C=C2O1 KDMGQPNVTKUNHV-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- RIAZZJBPJQWPIS-UHFFFAOYSA-N Silychristin Natural products COc1cc(ccc1O)C2OC3C(C=C(C=C3O)C4Oc5cc(O)cc(O)c5C(=O)C4O)C2CO RIAZZJBPJQWPIS-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229950005162 benexate Drugs 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- IAXUQWSLRKIRFR-SAABIXHNSA-N chembl2104696 Chemical compound C1C[C@@H](CNC(=N)N)CC[C@@H]1C(=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IAXUQWSLRKIRFR-SAABIXHNSA-N 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000007723 die pressing method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000936 membranestabilizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 229950004304 silidianin Drugs 0.000 description 1
- SEBFKMXJBCUCAI-DBMPWETRSA-N silybin Chemical compound C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-DBMPWETRSA-N 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- BMLIIPOXVWESJG-LMBCONBSSA-N silychristin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@@H](C3=C(C(=CC(=C3)[C@@H]3[C@H](C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-LMBCONBSSA-N 0.000 description 1
- BMLIIPOXVWESJG-UHFFFAOYSA-N silychristin A Natural products C1=C(O)C(OC)=CC(C2C(C3=C(C(=CC(=C3)C3C(C(=O)C4=C(O)C=C(O)C=C4O3)O)O)O2)CO)=C1 BMLIIPOXVWESJG-UHFFFAOYSA-N 0.000 description 1
- CYGIJEJDYJOUAN-JSGXPVSSSA-N silydianin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-JSGXPVSSSA-N 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
时间(分钟) | PEG400软胶囊 | 豆油软胶囊 | 国产片剂 | 进口片剂 |
5 | 6.57% | 4.63% | 6.14% | 5.21% |
10 | 11.44% | 3.56% | 12.95% | 8.32% |
20 | 95.33% | 12.81% | 54.50% | 22.75% |
30 | 98.75% | 31.02% | 69.30% | 45.56% |
45 | 99.90% | 46.17% | 74.32% | 56.17% |
60 | 101.03% | 68.28% | 73.83% | 72.90% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100494845A CN100402023C (zh) | 2003-06-21 | 2004-06-17 | 一种水飞蓟素软胶囊及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN03142848 | 2003-06-21 | ||
CN03142848.7 | 2003-06-21 | ||
CNB2004100494845A CN100402023C (zh) | 2003-06-21 | 2004-06-17 | 一种水飞蓟素软胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1572293A true CN1572293A (zh) | 2005-02-02 |
CN100402023C CN100402023C (zh) | 2008-07-16 |
Family
ID=34523657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100494845A Expired - Lifetime CN100402023C (zh) | 2003-06-21 | 2004-06-17 | 一种水飞蓟素软胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100402023C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102066364A (zh) * | 2008-06-26 | 2011-05-18 | 阿格拉集团公司 | 黄酮木脂素与具备改良的水溶解性的氨基酸的组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1274549B (it) * | 1995-05-23 | 1997-07-17 | Indena Spa | Uso di flavanolignani per la preparazione di medicamenti ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno |
KR100342942B1 (ko) * | 1999-07-05 | 2002-07-02 | 민경윤 | 카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물 |
DE10053384A1 (de) * | 2000-10-27 | 2002-05-08 | Bionorica Arzneimittel Gmbh | Pharmazeutische Zubereitung aus Mariendistel und Terpenen |
-
2004
- 2004-06-17 CN CNB2004100494845A patent/CN100402023C/zh not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102066364A (zh) * | 2008-06-26 | 2011-05-18 | 阿格拉集团公司 | 黄酮木脂素与具备改良的水溶解性的氨基酸的组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN100402023C (zh) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101600439B (zh) | 甘草酸或其盐的口服药物组合物及其制备方法 | |
CN102600132A (zh) | 一种含氨磺必利的口服制剂 | |
CN107049944A (zh) | 一种可实现索拉非尼和姜黄素同时给药的聚合物胶束及其制备方法 | |
CN1857676A (zh) | 一种莪术油微胶囊制剂及其制备方法 | |
CN1436527A (zh) | 格列美脲滴丸 | |
CN107028910A (zh) | 一种黄芩苷单层渗透泵片的制备方法 | |
TWI684451B (zh) | 水飛薊賓注射劑及其製備方法 | |
CN1772084A (zh) | 一种通舒口爽片及其制备方法 | |
CN1572293A (zh) | 一种水飞蓟素软胶囊及其制备方法 | |
CN112043679B (zh) | 一种含喹唑啉类化合物的软胶囊制剂及其制备方法 | |
CN1282459C (zh) | 黄体酮胶丸及制备方法 | |
CN101513393A (zh) | 一种水飞蓟素软胶囊及其制备方法 | |
CN1235576C (zh) | 阿魏酸钠的缓释剂型及其制备方法 | |
CN103202810A (zh) | 一种猕猴桃根多糖脂质体及其制备方法 | |
CN1939403A (zh) | 一种复方丹参注射剂的制备方法 | |
CN1069519C (zh) | 草乌甲素软胶囊及其生产方法 | |
CN1543942A (zh) | 山楂叶总黄酮软胶囊制剂及其制备方法 | |
CN1561993A (zh) | 水飞蓟素滴丸及其制备方法 | |
CN116850248B (zh) | 咳克平胶囊及其制备方法 | |
CN1481883A (zh) | 灯盏细辛软胶囊制剂及其制备方法 | |
CN100346782C (zh) | 一种含氨基酸的维生素c组合物 | |
CN1259038C (zh) | 柴胡软胶囊制剂及其制备方法 | |
CN100367954C (zh) | 穿心莲内酯软胶囊制剂及其制备方法 | |
CN1069520C (zh) | 灯盏花素软胶囊及其生产方法 | |
CN1628799A (zh) | 含有丁香叶提取物的软胶囊及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WUHU LUYE PHARMACY CO., LTD. Free format text: FORMER OWNER: LUYE NATURAL MEDICINAL RESEARCH DEVELOPING CO., LTD., SHANDONG PROV. Effective date: 20090424 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090424 Address after: Anhui province Wuhu City Jiuhua Road No. 116 Patentee after: WUHU LUYE PHARMACEUTICAL Co.,Ltd. Address before: No. 9, Po Yuen Road, Laishan District, Yantai, Shandong Patentee before: SHANDONG LUYE NATURAL DRUG RESEARCH AND DEVELOPMENT CO.,LTD. |
|
CX01 | Expiry of patent term |
Granted publication date: 20080716 |